ABC294735

Overview

ABC294735 is an orally active SK1/SK2 inhibitor. Combination of ABC294735 with Sorafenib ( HY-10201 ) reduces pERK . ABC294735 exhibits anticancer activity against pancreatic adenocarcinoma and renal cell carcinoma. ABC294735 can be used in research related to pancreatic adenocarcinoma and renal cell carcinoma.

Application

Products | Products > Disease Areas > Pancreatic Cancer | Products > Disease Areas > Digestive System Cancer | Products > Disease Areas > Renal Cancer | Products > Disease Areas > Cancer | Products > Disease Areas > Digestive System Disease | Products > Disease Areas > Urogenital Disease | Products > Disease Areas > Urogenital Cancer | Products > Signaling Pathways > Immunology/Inflammation | Products > Signaling Pathways > Cell Cycle/DNA Damage | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Immunotherapy | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Signaling Pathways > SphK | Products > Signaling Pathways > PERK

Product Information

• Catalog No.: HY-112385
• CAS No.: 917236-13-6
• Molecular Formula: C25H28ClNO3
• Molecular Weight: 425.95
• Storage: Please store the product under the recommended conditions in the Certificate of Analysis.

Source

Original product source